← back to search

Zhenwei Han

Hebei Medical University · CN
Area of research
Molecular Biology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Ferroptosis and cancer prognosis, Cancer-related molecular mechanisms research, RNA modifications and cancer, and Circular RNAs in diseases.
h-index
15
citations
772
works
47
NIH funding
primary concept
email

Recent publications

AL161431.1 is identified as a biomarker for bladder cancer progression and immunotherapy response
Scientific Reports 2025cited by 1position: middledoi
Polymorphisms in the <scp>FTO</scp> Gene and Their Association With Cancer Risk: A Comprehensive Review and Meta‐Analysis
Cancer Reports 2025cited by 0position: lastdoi
<i>MMP-9</i> gene polymorphisms on cancer risk: an updated systematic review and meta-analysis
Nucleosides Nucleotides & Nucleic Acids 2024cited by 4position: middledoi
Genetically predicted asthma and the risk of abnormal spermatozoa
Frontiers in Genetics 2024cited by 1position: middledoi
Predicting surgical efficacy and diagnosing histological inflammation: the clinical significance of prostate exosome proteins in benign prostatic hyperplasia
Translational Andrology and Urology 2024cited by 0position: middledoi
[Causal relationship between obesity and male infertility: A two-sample Mendelian randomization study].
PubMed 2024cited by 0position: middle
ERβ-regulated circATP2B1/miR-204–3p/TWIST1 positive feedback loop facilitates epithelial to mesenchymal transition in clear cell renal cell carcinoma
Translational Oncology 2024cited by 0position: lastdoi
CDK13 promotes lipid deposition and prostate cancer progression by stimulating NSUN5-mediated m5C modification of ACC1 mRNA
Cell Death and Differentiation 2023cited by 89position: middledoi
SF3B4 promotes Twist1 expression and clear cell renal cell carcinoma progression by facilitating the export of KLF 16 mRNA from the nucleus to the cytoplasm
Cell Death and Disease 2023cited by 22position: middledoi
Cuproptosis related gene PDHB is identified as a biomarker inversely associated with the progression of clear cell renal cell carcinoma
BMC Cancer 2023cited by 21position: lastdoi
DDX58 expression promotes inflammation and growth arrest in Sertoli cells by stabilizing p65 mRNA in patients with Sertoli cell-only syndrome
Frontiers in Immunology 2023cited by 7position: middledoi
Downregulated RBM5 Enhances CARM1 Expression and Activates the PRKACA/GSK3β Signaling Pathway through Alternative Splicing-Coupled Nonsense-Mediated Decay
Cancers 2023cited by 7position: middledoi
ESR2 polymorphisms on prostate cancer risk: A systematic review and meta-analysis
Medicine 2023cited by 5position: lastdoi
MNS16A polymorphism of the <i>TERT</i> gene on cancer risk: a systematic review and meta-analysis
Nucleosides Nucleotides & Nucleic Acids 2023cited by 3position: middledoi
eNOS polymorphisms on male infertility: An updated systematic review and meta-analysis
Medicine 2023cited by 2position: middledoi
Cuproptosis related gene PDHB was identified as a biomarker and its up-regulation inhibited the invasion of renal clear cell carcinoma
Research Square 2023cited by 0position: lastdoi
Neutrophil extracellular traps-associated modification patterns depict the tumor microenvironment, precision immunotherapy, and prognosis of clear cell renal cell carcinoma
Frontiers in Oncology 2022cited by 16position: middledoi
Estrogen receptor beta increases clear cell renal cell carcinoma stem cell phenotype via altering the circPHACTR4/miR‐34b‐5p/c‐Myc signaling
The FASEB Journal 2022cited by 14position: lastdoi
Integrative Analysis Identifies TCIRG1 as a Potential Prognostic and Immunotherapy-Relevant Biomarker Associated with Malignant Cell Migration in Clear Cell Renal Cell Carcinoma
Cancers 2022cited by 13position: middledoi
<i>ACPY2</i> gene polymorphisms on cancer risk: a systematic review and meta-analysis
Nucleosides Nucleotides & Nucleic Acids 2022cited by 3position: lastdoi
ESR2 polymorphisms on prostate cancer risk: A systematic review and meta-analysis
Research Square 2022cited by 1position: lastdoi
<i>ACPY2</i> gene polymorphisms on cancer risk: a systematic review and meta-analysis
Figshare 2022cited by 0position: lastdoi
Prestenting Versus Nonprestenting on the Outcomes of Flexible Ureteroscopy for Large Upper Urinary Stones: A Systematic Review and Meta-Analysis
Urologia Internationalis 2021cited by 22position: lastdoi
Right laparoscopic adrenalectomy vs. left laparoscopic adrenalectomy: a systematic review and meta-analysis.
Videosurgery and Other Miniinvasive Techniques 2021cited by 7position: lastdoi
Efficacy and safety of laparoendoscopic single-site adrenalectomy versus conventional laparoscopic adrenalectomy: an updated systematic review and meta-analysis.
Videosurgery and Other Miniinvasive Techniques 2021cited by 5position: lastdoi
Five <i>MDM4</i> gene polymorphisms on cancer risk: An updated systematic review and meta-analysis
The International Journal of Biological Markers 2021cited by 3position: lastdoi
Laparoscopic adrenalectomy (LA) vs open adrenalectomy (OA) for pheochromocytoma (PHEO): A systematic review and meta-analysis
European Journal of Surgical Oncology 2020cited by 65position: lastdoi
Targeting the ERβ/Angiopoietin-2/Tie-2 signaling-mediated angiogenesis with the FDA-approved anti-estrogen Faslodex to increase the Sunitinib sensitivity in RCC
Cell Death and Disease 2020cited by 43position: middledoi
Efficacy and safety of various surgical treatments for proximal ureteral stone ≥10mm: A systematic review and network meta-analysis
International braz j urol 2020cited by 28position: lastdoi
Development and validation of a six-RNA binding proteins prognostic signature and candidate drugs for prostate cancer
Genomics 2020cited by 25position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Zhihai Teng · Hebei Medical University20 papers (2019–2025)Yaxuan Wang · Yunnan Agricultural University15 papers (2019–2024)Zhan Yang · Qingdao University14 papers (2019–2023)Yanping Zhang · Hubei University14 papers (2019–2025)Xueliang Chang · Hebei Medical University13 papers (2020–2024)Jingdong Li · North Sichuan Medical University11 papers (2019–2024)Junfei Gu · Hebei Medical University8 papers (2019–2023)Hu Wang · North Sichuan Medical University8 papers (2022–2024)Yaxuan Wang · Southwestern University of Finance and Economics7 papers (2021–2025)Fengran Guo · Hebei Medical University6 papers (2023–2025)Xiaolu Wang · Heidelberg University5 papers (2018–2023)Lei Gao · Fujian Medical University5 papers (2019–2022)Chenggen Jin · Hebei Medical University4 papers (2023–2025)Shuyuan Yeh · University of Rochester Medical Center4 papers (2018–2022)Jingdong Li · North Sichuan Medical University4 papers (2020–2023)Chawnshang Chang · University of Rochester Medical Center3 papers (2018–2020)Changbao Qu · Yale University3 papers (2023–2023)Yin Sun · Shenyang Pharmaceutical University3 papers (2018–2020)Bao‐Sai Lu · Hebei Medical University3 papers (2019–2025)Xingyu He · Southwest Petroleum University3 papers (2023–2024)